Company Filing History:
Years Active: 2010-2013
Title: **Innovator Jurgen Meven and His Contributions to Pharmaceutical Technology**
Introduction
Jurgen Meven, an esteemed inventor based in Mainz, Germany, has made notable strides in the field of pharmaceutical preparations. With a keen focus on innovative materials, Meven holds two patents that significantly impact the industry.
Latest Patents
Meven's latest patents revolve around the use of dicalcium phosphate anhydride powder. The first patent details a formulation where at least 50% by weight of the powder has a grain size between 45 and 150 µm, a maximum of 50% is below 45 µm, and no more than 5% exceeds 150 µm. This powder is characterized by a bulk density ranging from 1000 to 1500 g/l and a specific surface area of less than 5 m²/g, which makes it suitable for direct tableting or capsule filling in pharmaceutical formulations.
His second patent also describes the properties of dicalcium phosphate anhydride powder, stating that at least 50 wt. % has a particle size within 45 to 150 µm. Additionally, it boasts a maximum of 50 wt. % under 45 µm and a maximum of 5 wt. % over 150 µm, with a bulk density of 1000 to 5000 g/l and a specific surface area of less than 5 m²/g. This innovation is particularly useful for directly tablet or encapsulate various pharmaceutical preparations.
Career Highlights
Jurgen Meven has built his career within Chemische Fabrik Budenheim KG, where he has demonstrated exceptional ingenuity and technical expertise. His contributions to the company have been crucial in advancing their pharmaceutical product line.
Collaborations
Meven collaborates with esteemed colleagues, including Erhard Fischer and Gerhard Scheuer. Together, they work towards enhancing the quality and efficiency of pharmaceutical materials, contributing to significant advancements in the industry.
Conclusion
Jurgen Meven continues to be a prominent figure in the field of pharmaceutical innovation. His patents not only showcase his expertise but also highlight his commitment to improving the formulation processes of pharmaceutical products. As the industry progresses, Meven's inventions will undoubtedly play a pivotal role in shaping the future of drug delivery systems.